Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Gatehouse Bio logo — A TechBio company utilizing AI to decode the landscape of sm...

Gatehouse Bio

A TechBio company utilizing AI to decode the landscape of small RNAs (sRNAs) and design precision oligonucleotides

Founded 2020 United States Natick, United States 11 employees Convertible Note Total: $7.95M Biotechnology

General Information

Company Name Gatehouse Bio
Founded Year 2020
Location United States Natick, United States +1
Employees 11
Industries Biotechnology
Funding Stage Convertible Note
Social

Get notified when Gatehouse Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Gatehouse Bio

Gatehouse Bio is a groundbreaking TechBio company harnessing the power of artificial intelligence to decipher the complex realm of small RNAs (sRNAs) and craft precision oligonucleotides. Founded in 2018 and headquartered in the United States, the company is dedicated to decoding sRNA isoforms for the development of biomarker-guided precision oligonucleotide therapeutics. This is achieved through their innovative AI-powered Code-Breaker™ Platform, which enables the identification and characterization of disease-associated isoforms and the digital design of therapeutics to counteract their effects. The last known investment for Gatehouse Bio was a Convertible Note funding round on 20 September 2023. Notable investors in this round included SOSV and indiebio, signifying the growing interest in the company's innovative approach within the Biotechnology sector. Gatehouse Bio's compelling focus on utilizing AI to unravel the mysteries of sRNAs and design precise therapeutics positions it as a promising player in the biotech landscape, offering potential for significant impact and growth in the future.

Taxonomy: TechBio, small RNA, sRNA, oligonucleotides, RNA therapeutics, in silico, digital drug design, precision medicines

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 2
Investor Investor
20 Sep 2023
Seed Round •••••• 2
Investor Investor
30 Sep 2022
Convertible Note •••••• 2
Investor Investor
23 Jun 2022
Seed Round •••••• 2
Investor Investor
08 Dec 2021
Series A •••••• 2
Investor Investor
15 Jan 2021

View All 7 Funding Rounds

Gatehouse Bio Alternatives & Competitors

Gatehouse Bio vs
Rona Therapeutics
Rona Therapeutics China

Empower Great People To Do Great Things

Series A
10 employees
Biotechnology, Health Care
Gatehouse Bio vs
Single Helix Genomics
Single Helix Genomics United States

Personalized mRNA synthesis and therapeutics on-demand

Seed
1 employees
Biotechnology, Health and Wellness
Gatehouse Bio vs
Skyhawk Therapeutics
Skyhawk Therapeutics United States

We Use Small Molecules To Modify RNA Splicing

Series Unknown
81 employees
Biotechnology, Health and Wellness
Also compare with: Gatehouse Bio vs Ribometrix Inc. Ribometrix Inc.

FAQ About Gatehouse Bio

A TechBio company utilizing AI to decode the landscape of small RNAs (sRNAs) and design precision oligonucleotides
Gatehouse Bio was founded in 2020.
Gatehouse Bio is headquartered in Natick, United States.
Gatehouse Bio operates in the following industries: Biotechnology.
Gatehouse Bio has approximately 11 employees.
Gatehouse Bio has completed 7 funding rounds, raising a total of $7.95M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Gatehouse Bio include Rona Therapeutics, Single Helix Genomics, Skyhawk Therapeutics, Redona Therapeutics, Ribometrix Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gatehouse Bio and Rona Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Gatehouse Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy